PleoPharma, Inc.Oct 7Press ReleasePLEOPHARMA, INC. Strengthens Patent Portfolio with Issuance of Two U.S. PatentsPHOENIXVILLE, Pa., Oct. 7, 2024 PleoPharma, Inc., a privately held company focused on Cannabis-related health issues, announced today that
PleoPharma, Inc.Sep 19Press ReleasePLEOPHARMA, INC. PARTICIPATES IN THE LIFE SCIENCES PA'S LIFE SCIENCE FUTURE CONFERENCEPHOENIXVILLE, Pa., Sept. 19, 2024 -- PleoPharma, Inc., a privately held company focused on cannabis related health issues, announced today..
PleoPharma, Inc.Sep 5Press ReleasePLEOPHARMA, INC. REPORTS POSITIVE PHASE 2b CLINICAL TRIAL DATA FOR MITIGATION OF CANNABIS WITHDRAWAL: A POTENTIAL FIRST IN CLASS TREATMENTPHOENIXVILLE, Pa., Sept. 5, 2024 -- PleoPharma, Inc., a privately held company focused on cannabis related health issues, announced today...
PleoPharma, Inc.Jun 30, 2023Company UpdatePleoPharma Inc. Completed a $17.5 Million Series A Financing Funding a Phase 2b Study for Cannabis Addiction and WithdrawalJune 2023 - PleoPharma Inc, announces it completed a Series A financing of $17.5 Million led by DynaGrow Capital, MintPharma Capital and...